{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:36:12Z","timestamp":1791412572599,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ccell.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:29:09Z","timestamp":1566469749000},"page":"237-249.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL"],"prefix":"10.1016","volume":"36","author":[{"given":"Salma","family":"Parvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Ramirez-Labrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomzion","family":"Aumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoQing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Weich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Cortizas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Sanchez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Gentles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bilbao-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro E.","family":"Verdun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2019.07.007_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","article-title":"Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody","volume":"61","author":"Agostinelli","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ccell.2019.07.007_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.07.007_bib3","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1056\/NEJMc0902616","article-title":"Molecular outcome prediction in diffuse large-B-cell lymphoma","volume":"360","author":"Alizadeh","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib4","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2019.07.007_bib5","doi-asserted-by":"crossref","first-page":"e1000110","DOI":"10.1371\/journal.pgen.1000110","article-title":"Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair","volume":"4","author":"Bennardo","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ccell.2019.07.007_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molcel.2011.03.019","article-title":"Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1","volume":"42","author":"Bothmer","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2019.07.007_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.20100244","article-title":"53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination","volume":"207","author":"Bothmer","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nsmb.1831","article-title":"53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers","volume":"17","author":"Bouwman","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ccell.2019.07.007_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1083\/jcb.201303073","article-title":"A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair","volume":"202","author":"Britton","year":"2013","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ccell.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.07.007_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molcel.2009.06.037","article-title":"A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency","volume":"35","author":"Cao","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2019.07.007_bib13","doi-asserted-by":"crossref","first-page":"150062","DOI":"10.1098\/rsob.150062","article-title":"LMO2 at 25 years: a paradigm of chromosomal translocation proteins","volume":"5","author":"Chambers","year":"2015","journal-title":"Open Biol."},{"key":"10.1016\/j.ccell.2019.07.007_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the end game: DNA double-strand break repair pathway choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2019.07.007_bib15","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2015-09-672352","article-title":"Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib18","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib19","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1084\/jem.20160635","article-title":"UNG protects B cells from AID-induced telomere loss","volume":"213","author":"Cortizas","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib20","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1182\/blood-2012-01-403154","article-title":"Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma","volume":"119","author":"Cubedo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib21","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/MCB.01639-13","article-title":"53BP1, BRCA1, and the choice between recombination and end joining at DNA double-strand breaks","volume":"34","author":"Daley","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2019.07.007_bib22","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.leu.2401913","article-title":"Identification of genes potentially involved in LMO2-induced leukemogenesis","volume":"14","author":"Davenport","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2019.07.007_bib23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1084\/jem.20122842","article-title":"DNA repair genes are selectively mutated in diffuse large B cell lymphomas","volume":"210","author":"de Miranda","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1230624","article-title":"Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching","volume":"339","author":"Di Virgilio","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccell.2019.07.007_bib25","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2010-07-293357","article-title":"Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex","volume":"117","author":"El Omari","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.molcel.2013.01.001","article-title":"A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice","volume":"49","author":"Escribano-Diaz","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2019.07.007_bib27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.07.007_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2013analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2019.07.007_bib30","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1093\/emboj\/17.16.4594","article-title":"The oncogenic T\u00a0cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T\u00a0cells","volume":"17","author":"Grutz","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2019.07.007_bib31","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2019.07.007_bib32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2009-09-244673","article-title":"Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)","volume":"116","author":"Hirose","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib33","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.07.007_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2019.07.007_bib35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ccell.2019.07.007_bib36","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2019.07.007_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2019.07.007_bib38","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/path.2109","article-title":"The significance of LMO2 expression in the progression of prostate cancer","volume":"211","author":"Ma","year":"2007","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccell.2019.07.007_bib40","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","article-title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"111","author":"Malumbres","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra032207","article-title":"Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency","volume":"350","author":"McCormack","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib42","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/onc.2011.542","article-title":"NPM-ALK signals through glycogen synthase kinase 3beta to promote oncogenesis","volume":"31","author":"McDonnell","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2019.07.007_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2019.07.007_bib44","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by clinical PARP inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2019.07.007_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1535-7163.MCT-13-0803","article-title":"Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib","volume":"13","author":"Murai","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2019.07.007_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymthe.2005.09.010","article-title":"The role of LMO2 in development and in T\u00a0cell leukemia after chromosomal translocation or retroviral insertion","volume":"13","author":"Nam","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2019.07.007_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2019.07.007_bib48","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib49","first-page":"587","article-title":"Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions","volume":"6","author":"Neale","year":"1995","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.ccell.2019.07.007_bib50","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nsmb.3251","article-title":"53BP1 fosters fidelity of homology-directed DNA repair","volume":"23","author":"Ochs","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ccell.2019.07.007_bib51","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1101\/gad.13.20.2633","article-title":"XRCC3 promotes homology-directed repair of DNA damage in mammalian cells","volume":"13","author":"Pierce","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2019.07.007_bib52","doi-asserted-by":"crossref","first-page":"362ps317","DOI":"10.1126\/scitranslmed.aaf9246","article-title":"Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action","volume":"8","author":"Pommier","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bjh.14793","article-title":"A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma","volume":"182","author":"Pratt","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccell.2019.07.007_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2019.07.007_bib55","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1101\/gad.12.24.3831","article-title":"Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations","volume":"12","author":"Richardson","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2019.07.007_bib56","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib57","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.ccell.2019.07.007_bib58","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/emboj\/17.2.598","article-title":"Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death","volume":"17","author":"Sonoda","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2019.07.007_bib59","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-16-3068","article-title":"The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma","volume":"23","author":"Soumerai","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2019.07.007_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.immunol.26.021607.090248","article-title":"Mechanism and regulation of class switch recombination","volume":"26","author":"Stavnezer","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2019.07.007_bib61","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","article-title":"The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia","volume":"108","author":"Van Vlierberghe","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrc1321","article-title":"Tracing the network connecting BRCA and Fanconi anaemia proteins","volume":"4","author":"Venkitaraman","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2019.07.007_bib63","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","article-title":"The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in\u00a0vitro and in\u00a0vivo","volume":"116","author":"Weston","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2019.07.007_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/emmm.201200229","article-title":"Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53","volume":"4","author":"Williamson","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ccell.2019.07.007_bib65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.6004\/jnccn.2016.0023","article-title":"Diffuse large B-cell lymphoma version 1.2016","volume":"14","author":"Zelenetz","year":"2016","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ccell.2019.07.007_bib66","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1231573","article-title":"53BP1 regulates DSB repair using Rif1 to control 5' end resection","volume":"339","author":"Zimmermann","year":"2013","journal-title":"Science"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610819303344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610819303344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:02:36Z","timestamp":1761523356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610819303344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1535610819303344"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2019.07.007","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}